Champions Oncology (CSBR) Operating Margin (2016 - 2025)
Historic Operating Margin for Champions Oncology (CSBR) over the last 16 years, with Q4 2025 value amounting to 1.23%.
- Champions Oncology's Operating Margin fell 42000.0% to 1.23% in Q4 2025 from the same period last year, while for Oct 2025 it was 3.68%, marking a year-over-year increase of 51500.0%. This contributed to the annual value of 8.0% for FY2025, which is 226600.0% up from last year.
- As of Q4 2025, Champions Oncology's Operating Margin stood at 1.23%, which was down 42000.0% from 3.77% recorded in Q3 2025.
- Champions Oncology's 5-year Operating Margin high stood at 26.4% for Q1 2025, and its period low was 21.44% during Q1 2024.
- Its 5-year average for Operating Margin is 3.56%, with a median of 2.0% in 2022.
- In the last 5 years, Champions Oncology's Operating Margin crashed by -255300bps in 2023 and then skyrocketed by 478500bps in 2025.
- Quarter analysis of 5 years shows Champions Oncology's Operating Margin stood at 2.23% in 2021, then crashed by -98bps to 0.05% in 2022, then plummeted by -34564bps to 16.89% in 2023, then soared by 132bps to 5.43% in 2024, then crashed by -77bps to 1.23% in 2025.
- Its last three reported values are 1.23% in Q4 2025, 3.77% for Q3 2025, and 16.24% during Q2 2025.